ArticlePloS one2024

Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy.

Felix Peisen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.